Literature DB >> 3016196

Myopathy with abnormal mitochondria, transient low electron transport capacity in the respiratory chain, and absence of energy transduction at sites 1 and 2 in vitro.

U Trockel, H R Scholte, K V Toyka, H F Busch, I E Luyt-Houwen, J A Berden.   

Abstract

A male adult with exercise-related myalgia and weakness from the age of 17 years, developed contractions after moderate exertion which were electrically silent. Triglyceride loading or prolonged fasting provoked excessive ketosis. His isolated muscle mitochondria had severe blockade of the respiratory chain, particularly of NADH-CoQ reductase. After 1.5 years a second biopsy was performed. The electron transport capacity of the respiratory chain was much improved, but now a lesion was observed in energy transduction of sites 1 and 2 of the respiratory chain. The unexpected abolishment of respiratory chain blockade was paralleled by only mild clinical improvement.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016196      PMCID: PMC1028845          DOI: 10.1136/jnnp.49.6.645

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  Coenzyme A and carnitine distribution in normal and ischemic hearts.

Authors:  J A Idell-Wenger; L W Grotyohann; J R Neely
Journal:  J Biol Chem       Date:  1978-06-25       Impact factor: 5.157

2.  A standardized forearm ischemic exercise test.

Authors:  T L Munsat
Journal:  Neurology       Date:  1970-12       Impact factor: 9.910

3.  Glutaric aciduria type II: multiple defects in isolated muscle mitochondria and deficient beta-oxidation in fibroblasts.

Authors:  P D Mooy; M A Giesberts; H H van Gelderen; H R Scholte; I E Luyt-Houwen; H Przyrembel; W Blom
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

Review 4.  Mitochondrial myopathies. Clinical, morphological and biochemical aspects.

Authors:  R C Sengers; A M Stadhouders; J M Trijbels
Journal:  Eur J Pediatr       Date:  1984-02       Impact factor: 3.183

5.  Changes in tissue levels of carnitine and other metabolites during myocardial ischemia and anoxia.

Authors:  A L Shug; J H Thomsen; J D Folts; N Bittar; M I Klein; J R Koke; P J Huth
Journal:  Arch Biochem Biophys       Date:  1978-04-15       Impact factor: 4.013

6.  Adenine nucleotide transport in sonic submitochondrial particles. Kinetic properties and binding of specific inhibitors.

Authors:  G J Lauquin; C Villiers; J W Michejda; L V Hryniewiecka; P V Vignais
Journal:  Biochim Biophys Acta       Date:  1977-05-11

7.  An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes.

Authors:  P G Barth; H R Scholte; J A Berden; J M Van der Klei-Van Moorsel; I E Luyt-Houwen; E T Van 't Veer-Korthof; J J Van der Harten; M A Sobotka-Plojhar
Journal:  J Neurol Sci       Date:  1983-12       Impact factor: 3.181

8.  Benign infantile mitochondrial myopathy due to reversible cytochrome c oxidase deficiency.

Authors:  S DiMauro; J F Nicholson; A P Hays; A B Eastwood; A Papadimitriou; R Koenigsberger; D C DeVivo
Journal:  Ann Neurol       Date:  1983-08       Impact factor: 10.422

9.  Muscle wasting and carbohydrate homeostasis in Duchenne muscular dystrophy.

Authors:  M W Haymond; K E Strobel; D C DeVivo
Journal:  Neurology       Date:  1978-12       Impact factor: 9.910

10.  Carnitine palmityl transferase deficiency: myoglobinuria and respiratory failure.

Authors:  T Bertorini; Y Y Yeh; C Trevisan; E Stadlan; S Sabesin; S DiMauro
Journal:  Neurology       Date:  1980-03       Impact factor: 9.910

View more
  2 in total

Review 1.  The biochemical basis of mitochondrial diseases.

Authors:  H R Scholte
Journal:  J Bioenerg Biomembr       Date:  1988-04       Impact factor: 2.945

Review 2.  Problems with the biochemical diagnosis in mitochondrial (encephalo-)myopathies.

Authors:  J M Trijbels; H R Scholte; W Ruitenbeek; R C Sengers; A J Janssen; H F Busch
Journal:  Eur J Pediatr       Date:  1993-03       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.